FDA Clears Multi-Modality Breast Biopsy and Tissue Removal System
The newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
Read MoreJan 15, 2026 | Clearances | 0 |
The newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
Read MoreA misassembly defect in a specific lot of Ivenix primary administration sets could cause reverse flow, delayed infusion, or serious patient harm, prompting a Class I recall.
Read MoreThe removal is tied to incorrect software installations that could result in inaccurate flow rates and user confusion during clinical use.
Read MoreJan 5, 2026 | Inside HTM | 0 |
The most-read articles published on 24×7 in 2025, ranked by page views.
Read MoreThe company is asking facilities to stop using affected mounts and return unused stock; cracks can cause leakage that may restrict ventilation if uncompensated.
Read More